Literature DB >> 12923190

Mouse 3-phosphoinositide-dependent protein kinase-1 undergoes dimerization and trans-phosphorylation in the activation loop.

Michael J Wick1, Fresnida J Ramos, Hui Chen, Michael J Quon, Lily Q Dong, Feng Liu.   

Abstract

Activation of mouse 3-phosphoinositide-dependent protein kinase-1 (mPDK1) requires phosphorylation at a conserved serine residue, Ser244, in the activation loop. However, the mechanism by which mPDK1 is phosphorylated at this site remains unclear. We have found that kinase-defective mPDK1 (mPDK1KD), but not a kinase-defective mPDK1 in which Ser244 was replaced with alanine (mPDK1KD/S244A), is significantly phosphorylated in intact cells and is a direct substrate of wild-type mPDK1 fused to the yellow fluorescence protein. Phosphoamino acid analysis and phosphopeptide mapping studies revealed that mPDK1 trans-autophosphorylation occurred mainly on Ser244. On the other hand, Ser399 and Thr516, two recently identified autophosphorylation sites of mPDK1, are phosphorylated primarily through a cis mechanism. In vivo labeling studies revealed that insulin stimulated both mPDK1KD and mPDK1KD/S244A phosphorylation in Chinese hamster ovary cells overexpressing the insulin receptor. However, Western blot analysis using a phosphospecific antibody revealed no increase in insulin-stimulated phosphorylation of Ser244 in these cells overexpressing mPDK1. mPDK1 undergoes dimerization in cells and this self-association is enhanced by kinase inactivation. Deletion of the extreme C terminus disrupts mPDK1 dimerization and Ser244 trans-phosphorylation, suggesting that dimerization is important for mPDK1 trans-phosphorylation. Taken together, our results show that mPDK1 autophosphorylation occurs at multiple sites through both cis and trans mechanisms and suggest that dimerization and trans-phosphorylation may serve as mechanisms to regulate PDK1 activity in cells.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12923190     DOI: 10.1074/jbc.M304172200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  29 in total

1.  Akt activation by Ca2+/calmodulin-dependent protein kinase kinase 2 (CaMKK2) in ovarian cancer cells.

Authors:  Angela M Gocher; Gissou Azabdaftari; Lindsey M Euscher; Shuhang Dai; Loukia G Karacosta; Thomas F Franke; Arthur M Edelman
Journal:  J Biol Chem       Date:  2017-06-20       Impact factor: 5.157

2.  Expression of 3-phosphoinositide-dependent protein kinase 1 in colorectal cancer as a potential therapeutic target.

Authors:  Zhenglei Xu; Bihong Liao; Ru Zhang; Jun Yao; Ruiyue Shi; Lisheng Wang
Journal:  Med Oncol       Date:  2015-06-09       Impact factor: 3.064

3.  Multiple implications of 3-phosphoinositide-dependent protein kinase 1 in human cancer.

Authors:  Yuwen Li; Keum-Jin Yang; Jongsun Park
Journal:  World J Biol Chem       Date:  2010-08-26

4.  Phosphatidylserine binding is essential for plasma membrane recruitment and signaling function of 3-phosphoinositide-dependent kinase-1.

Authors:  Nathan Lucas; Wonhwa Cho
Journal:  J Biol Chem       Date:  2011-10-04       Impact factor: 5.157

5.  Phosphoinositide-dependent phosphorylation of PDK1 regulates nuclear translocation.

Authors:  Michael P Scheid; Michael Parsons; James R Woodgett
Journal:  Mol Cell Biol       Date:  2005-03       Impact factor: 4.272

6.  Mechanisms of sphingosine-1-phosphate-induced akt-dependent smooth muscle cell migration.

Authors:  Elisa Roztocil; Suzanne M Nicholl; Mark G Davies
Journal:  Surgery       Date:  2008-09-11       Impact factor: 3.982

7.  3-Hydroxyanthranilic acid inhibits PDK1 activation and suppresses experimental asthma by inducing T cell apoptosis.

Authors:  Tomoko Hayashi; Ji-Hun Mo; Xing Gong; Cyprian Rossetto; Angela Jang; Lucinda Beck; Gregory I Elliott; Irina Kufareva; Ruben Abagyan; David H Broide; Jongdae Lee; Eyal Raz
Journal:  Proc Natl Acad Sci U S A       Date:  2007-11-14       Impact factor: 11.205

8.  Mitogen-activated protein kinase upregulates the dendritic translation machinery in long-term potentiation by controlling the mammalian target of rapamycin pathway.

Authors:  Panayiotis Tsokas; Tao Ma; Ravi Iyengar; Emmanuel M Landau; Robert D Blitzer
Journal:  J Neurosci       Date:  2007-05-30       Impact factor: 6.167

9.  Selective disruption of insulin-like growth factor-1 (IGF-1) signaling via phosphoinositide-dependent kinase-1 prevents the protective effect of IGF-1 on human cancer cell death.

Authors:  A Teresa Alberobello; Vittoria D'Esposito; Daniela Marasco; Nunzianna Doti; Menotti Ruvo; Roberto Bianco; Giampaolo Tortora; Iolanda Esposito; Francesca Fiory; Claudia Miele; Francesco Beguinot; Pietro Formisano
Journal:  J Biol Chem       Date:  2009-12-31       Impact factor: 5.157

10.  c-Jun regulates phosphoinositide-dependent kinase 1 transcription: implication for Akt and protein kinase C activities and melanoma tumorigenesis.

Authors:  Pablo Lopez-Bergami; Hyungsoo Kim; Antimone Dewing; James Goydos; Stuart Aaronson; Ze'ev Ronai
Journal:  J Biol Chem       Date:  2009-11-12       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.